3 completed. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Atrophy, Geographic: new trials by email Literature Review of Atrophy, Geographic trials Research Report on Atrophy, Geographic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2/3 Study of ALK-001 in Geographic Atrophy ALK-001 oral capsule, Placebo oral capsule - Geographic Atrophy, Age Related Macular Degeneration | Phase 2 / Phase 3 | Completed | Alkeus Pharmaceuticals, Inc. | 200 | 2019-05-07 | 2025-11-03 |
| Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers GSK933776 for SQ administration, GSK933776 for IM administration, GSK933776 for IV administration - Atrophy, Geographic | Phase 1 | Completed | GlaxoSmithKline | 36 | 2014-01-22 | 2017-05-15 |
| Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration GSK933776, Placebo - Atrophy, Geographic | Phase 2 | Completed | GlaxoSmithKline | 191 | 2011-06-01 | 2017-05-05 |
Geographic Atrophy (3) · Macular Degeneration (2) · Plaque, Amyloid (1)
Eye Diseases (3) · Retinal Degeneration (3) · Retinal Diseases (3) · Macular Degeneration (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1)
Organization and Administration (1)
GlaxoSmithKline (2) · Alkeus Pharmaceuticals, Inc. (1)
United States (3) · Canada (1)